Epidemic Alert and Response in Emergencies

Total Page:16

File Type:pdf, Size:1020Kb

Epidemic Alert and Response in Emergencies EEppiiddeemmiicc AAlleerrtt aanndd RReessppoonnssee iinn EEmmeerrggeenncciieess Dr. Mike Ryan, Director Dep artm ent of E p id em ic and P and em ic A lert and Res p ons e C om m u nicab le Dis eas e C lu s ter 2 7 th N ov em b er 2 0 0 6 Epidemic and Pandemic Alert and Response OOVVEERRVVIIEEWW BB aacckkgg rroouu nndd aanndd PP rriinncciipp lleess ooff EE pp iidd eemm iicc AA lleerrtt aanndd RReess pp oonnss ee PP rreepp aarreedd nneess ss PP llaannnniinngg EE pp iidd eemm iicc DDeetteeccttiioonn,, IInnvv eess ttiigg aattiioonn aanndd RReess pp oonnss ee IInntteerrnnaattiioonnaall AA ss pp eeccttss Epidemic and Pandemic Alert and Response EEppiiddeemmiiccss aanndd PPaannddeemmiiccss hhaavvee sshhaappeedd oouurr hhiissttoorryy…… 1stMillenium SpreadM ofi d19d18le In Aflugenezsa Pandemic in USA Epidemic and Pandemic Alert and Response TThheeyy ccoonnttiinnuuee ttoo tthhrreeaatteenn uuss.... …and place sudden intense demands on national and international health systems ….on some occasions have brought systems to the point of collapse W HO has verified more than 1240 events between January 2001 and October 2006 Epidemic and Pandemic Alert and Response EEppiiddeemmiicc CCoonnttrrooll RReeqquuiirreess…… 1 . S trong national p u b lic h ealth s ys tem s and cap acity 2 . S p ecific p rep ared nes s for key p riority d is eas e th reats (e.g . S O P s , d iag nos tics , d ru g s , v accines , p rotectiv e eq u ip m ent, containm ent m eas u res ) 3 . A n effectiv e international s ys tem and p artners h ip for coord inated alert and res p ons e Epidemic and Pandemic Alert and Response WW hhaatt iiss aann oouuttbbrreeaakk//eeppiiddeemmiicc?? A n u nu s u al occu rrence of m ore cas es of d is eas e th an ex p ected in a g iv en area am ong a s p ecific g rou p of p eop le ov er a p articu lar p eriod of tim e A p u b lic h ealth em erg ency A n econom ic em erg ency A p olitical em erg ency S u rv eillance failu re C ontrol failu re A n ev ent req u iring rap id and coord inated action (…a s tres s tes t for th e p u b lic h ealth s ys tem !!) A n op p ortu nity ! Epidemic and Pandemic Alert and Response SSppeecciiffiicc ddeemmaannddss ww hheenn iinnvveessttiiggaattiinngg oouuttbbrreeaakkss • Unexpected event • Need to act quickly • Need for rapid control • Many players Systematic approach Epidemic and Pandemic Alert and Response EEppiiddeemmiicc FFiieelldd OOppeerraattiioonnss -- FFuunnccttiioonnss Traditional Medical Burial Screening Clinical Teams healers Anthropology IN / OUT trials Posters Psycho Social Case Barrier Radio Social Nursing Mobilization and support Management Community Discussion Health Education W ater Sanitation Media Coordination Environment Mobile Contact Teams Surveillance Tracing Logistics Roads Case and Security Epidemiology Finding Police Laboratory Sample Data Collection Transports Reporting Salaries Management Vehicles Results Testing Epidemic and Pandemic Alert and Response OOuuttbbrreeaakk AAlleerrtt aanndd RReessppoonnssee First Late Delayed Case Detection Response 90 80 70 60 CASES 50 Opportunity 40 for control 30 20 10 0 1 4 7 0 3 6 9 2 5 8 1 4 7 0 1 1 1 1 2 2 2 3 3 3 4 DAY Epidemic and Pandemic Alert and Response OOuuttbbrreeaakk AAlleerrtt aanndd RReessppoonnssee Early Rapid Detection Response 90 80 70 Control 60 CASES 50 Opportunity 40 30 20 10 0 1 4 7 0 3 6 9 2 5 8 1 4 7 0 1 1 1 1 2 2 2 3 3 3 4 DAY Epidemic and Pandemic Alert and Response OObbjjeeccttiivveess ooff EEppiiddeemmiicc PPrreeppaarreeddnneessss,, AAlleerrtt aanndd RReessppoonnssee 1.Prevention/Anticipation/prediction • so that epidemics be prevented (e.g. measles) 2. Early detection • to know when there is a problem (e.g. EW ARS) 3.Rapid Response • SOPs/ staff/supplies (in place before epidemic) 4. Effective Response • appropriate control methods • good co-ordination • adequate resources and logistics • after-action evaluation Epidemic and Pandemic Alert and Response EEppiiddeemmiicc AAlleerrtt aanndd RReessppoonnssee AA nnttiicciipp aattiioonn PP rreevv eennttiioonn PP rreepp aarreedd nneess ss DDeetteeccttiioonn RRiiss kk AA ss ss eess ss mm eenntt RRiiss kk CC oomm mm uu nniiccaattiioonn RReess pp oonnss ee EE vv aalluu aattiioonn Epidemic and Pandemic Alert and Response PPrreevveennttiioonn PPrreeppaarreeddnneessss PPllaannnniinngg Epidemic and Pandemic Alert and Response AAnnttiicciippaattiioonn aanndd PPrreevveennttiioonn K1 nnooww nn RRiiss kkss E p id em iolog ical P rofile (h is torical p rofile of ep id em ic th reats ) S p ecific ep id em ic th reats related to th e ev ent (flood /T s u nam i v s d is p lacem ent) PP rreevv eennttiioonn E d u cation/s ocial m ob ilis ation Im m u nis ation W ater/S anitation/H yg iene L iv ing cond itions /cam p d es ig n Epidemic and Pandemic Alert and Response PPrreeppaarreeddnneessss K1 nnooww tthh ee rriiss kkss SS eett PP rriioorriittiieess PP llaann CC oo--oorrdd iinnaattee IImm pp lleemm eenntt Epidemic and Pandemic Alert and Response PPrriioorriittyy SSeettttiinngg W hat are the major epidemic prone diseases ? W hat is the risk of an epidemic ? • time since last outbreak, frequency of outbreaks W hat would be the likely impact of an epidemic ? • Potential number of cases/deaths, likelihood of spread Control measures ? • Are effective and affordable measures available ? Resources ? • Do you have adequate resources ? Epidemic and Pandemic Alert and Response Priority setting - II Epidemic Risk Impact Control Resources prone disease measures Cholera High High X Meningitis Low High Measles Low Low JE High Low X Low High Malaria X Low Low Viral HF Epidemic and Pandemic Alert and Response EEppiiddeemmiicc PPrreeppaarreeddnneessss PPllaannnniinngg List the priority diseases Define the surveillance, preparedness and response measures to be implemented Identify responsibilities (who does what) Identify co-ordination mechanisms (leadership) Specify resources available for preparedness and response (budget) Epidemic and Pandemic Alert and Response EEppiiddeemmiicc PPrreeppaarreeddnneessss PPllaannnniinngg W hat should be done ? W ho should do it ? W hat resources or supplies will be required ? Epidemic and Pandemic Alert and Response CCoonnttrrooll mmeeaassuurreess aarree bbaasseedd oonn kknnoowwlleeddggee ooff:: DDiisseeaassee ttrraannssmmiissssiioonn reservoir, sources, routes IInnffeeccttiioouuss pprroocceessss exposure, infection, disease PPaatthhooggeenneessiiss ooff ddiisseeaassee ssttaattee target organs, virulence, immune response NNaattuurraall hhiissttoorryy EEffffeeccttiivveenneessss ooff ccoonnttrrooll mmeeaassuurreess Epidemic and Pandemic Alert and Response MM aajjoorr ttrraannssmmiissssiioonn rroouutteess Insects Vector borne Droplet Animals Sexual Food Direct Environmental Blood W ater Skin to skin Drop. nuclei Other Airborne Dust Epidemic and Pandemic Alert and Response DDooeess aa ppootteennttiiaall ccoonnttrrooll mmeeaassuurree rreedduuccee TTrraannssmmiissssiioonn EExxppoossuurree IInnffeeccttiioonn DDiisseeaassee ? DDeeaatthh DDiissaabbiilliittyy Epidemic and Pandemic Alert and Response PPrriinncciipplleess ooff ccoonnttrrooll P rev ent ex p os u re P rotect s u s cep tib les from infection P rev ent p rog res s ion from infection to d is eas e T reat cas es P re v e n t d e a th a n d d is a b ility œ P re v e n t fu rth e r tra n s m is s io n Interru p t trans m is s ion œ E n v iro n m e n ta l œ S o c ia l/b e h a v io u ra l œ L e g a l Epidemic and Pandemic Alert and Response Pathways of Disease Transmission HOST Exposure PATHOGEN D V E i e n r c v t Incubation e i c o r Period t r PATHOGEN Infection Disease Epidemic and PDaenatdhemic AleRret caonvedr yResponse Exposure HOST D V E Susceptibility i e n - previous exposure r c v - immunity e t i - compromise c o r - prophylaxis t r Infection Disease Death Recovery Epidemic and Pandemic Alert and Response Exposure HOST D V E i e n r c v e t i c o r t r General health Nutrition Infection Immunity Virulence Immune response Prophylaxis Disease Death Recovery Epidemic and Pandemic Alert and Response Exposure HOST D V E i e n r c v e t i c o r t r Infection Disease Treatment Death Recovery Epidemic and Pandemic Alert and Response Control W here does it fit in? Epidemic and Pandemic Alert and Response Points for control m easures Exposure 7 D V E i e n r c v 1 e 6t i c o r t r Infection 4 2 5 Disease 3 Death Recovery Epidemic and Pandemic AleDrti saanbdili tRyesponse Points for control m easures Exposure D V E i e n r c v Vaccination 1 e t i c o r t r Infection Disease Death Recovery Epidemic and Pandemic AleDrti saanbdili tRyesponse Points for control m easures Exposure D V E i e n r c v e t i c o r t r Infection Prophylaxis 2 Disease Death Recovery Epidemic and Pandemic AleDrti saanbdili tRyesponse Points for control m easures Exposure D V E i e n r c v e t i c o r t r Infection Treatment Disease Rehabilitation 3 Death Recovery Epidemic and Pandemic AleDrti saanbdili tRyesponse Points for control m easures Exposure D V E i e n r c v e t i c o r t r Isolation Infection 4 Treatment 5 Disease Death Recovery Epidemic and Pandemic AleDrti saanbdili tRyesponse Points for control m easures Exposure D V E 6 i e n r c v t Infection control e i o Vector mgt c r t r W ater treatment Infection Disease Death Recovery Epidemic and Pandemic AleDrti saanbdili tRyesponse Points for control Repellents m easures Exposure 7 Bednets D V E i e n r c v e t i c o r t r Infection Isolation Disease Death Recovery Epidemic and Pandemic AleDrti saanbdili tRyesponse Points for control
Recommended publications
  • Globalization and Infectious Diseases: a Review of the Linkages
    TDR/STR/SEB/ST/04.2 SPECIAL TOPICS NO.3 Globalization and infectious diseases: A review of the linkages Social, Economic and Behavioural (SEB) Research UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) The "Special Topics in Social, Economic and Behavioural (SEB) Research" series are peer-reviewed publications commissioned by the TDR Steering Committee for Social, Economic and Behavioural Research. For further information please contact: Dr Johannes Sommerfeld Manager Steering Committee for Social, Economic and Behavioural Research (SEB) UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) World Health Organization 20, Avenue Appia CH-1211 Geneva 27 Switzerland E-mail: [email protected] TDR/STR/SEB/ST/04.2 Globalization and infectious diseases: A review of the linkages Lance Saker,1 MSc MRCP Kelley Lee,1 MPA, MA, D.Phil. Barbara Cannito,1 MSc Anna Gilmore,2 MBBS, DTM&H, MSc, MFPHM Diarmid Campbell-Lendrum,1 D.Phil. 1 Centre on Global Change and Health London School of Hygiene & Tropical Medicine Keppel Street, London WC1E 7HT, UK 2 European Centre on Health of Societies in Transition (ECOHOST) London School of Hygiene & Tropical Medicine Keppel Street, London WC1E 7HT, UK TDR/STR/SEB/ST/04.2 Copyright © World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases 2004 All rights reserved. The use of content from this health information product for all non-commercial education, training and information purposes is encouraged, including translation, quotation and reproduction, in any medium, but the content must not be changed and full acknowledgement of the source must be clearly stated.
    [Show full text]
  • On Confinement and Quarantine Concerns on an SEIAR Epidemic
    S S symmetry Article On Confinement and Quarantine Concerns on an SEIAR Epidemic Model with Simulated Parameterizations for the COVID-19 Pandemic Manuel De la Sen 1,* , Asier Ibeas 2 and Ravi P. Agarwal 3 1 Campus of Leioa, Institute of Research and Development of Processes IIDP, University of the Basque Country, 48940 Leioa (Bizkaia), Spain 2 Department of Telecommunications and Systems Engineering, Universitat Autònoma de Barcelona, UAB, 08193 Barcelona, Spain; [email protected] 3 Department of Mathematics, Texas A & M University, 700 Univ Blvd, Kingsville, TX 78363, USA; [email protected] * Correspondence: [email protected] Received: 7 September 2020; Accepted: 30 September 2020; Published: 7 October 2020 Abstract: This paper firstly studies an SIR (susceptible-infectious-recovered) epidemic model without demography and with no disease mortality under both total and under partial quarantine of the susceptible subpopulation or of both the susceptible and the infectious ones in order to satisfy the hospital availability requirements on bed disposal and other necessary treatment means for the seriously infectious subpopulations. The seriously infectious individuals are assumed to be a part of the total infectious being described by a time-varying proportional function. A time-varying upper-bound of those seriously infected individuals has to be satisfied as objective by either a total confinement or partial quarantine intervention of the susceptible subpopulation. Afterwards, a new extended SEIR (susceptible-exposed-infectious-recovered) epidemic model, which is referred to as an SEIAR (susceptible-exposed-symptomatic infectious-asymptomatic infectious-recovered) epidemic model with demography and disease mortality is given and focused on so as to extend the above developed ideas on the SIR model.
    [Show full text]
  • World Health Organization Department of Communicable Disease Surveillance and Response
    WHO/CDS/CSR/2000.3 Global Outbreak Alert and Response. Report of a WHO meeting Geneva, Switzerland 26-28 April 2000 World Health Organization Department of Communicable Disease Surveillance and Response This document has been downloaded from the WHO/EMC Web site. The original cover pages and lists of participants are not included. See http://www.who.int/emc for more information. © World Health Organization This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors. The mention of specific companies or specific manufacturers' products does no imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. WHO/CDS/CSR/2000.3 Contents Executive Summary ………………………………………………………………………… 1 1. Introduction …………………………………………………………………………… 3 1.1 Opening ceremony ……………………………………………………………… 3 1.2 Participants and agenda ……………………………………………………….… 3 1.3 Global review …………………………………………………………………………. 3 2. Proceedings …………………………………………………………………………… 5 2.1 Outline of daily sessions …………………………………………………….. 5 2.2 Session 1: Outbreak Alert Systems ………………………………………….. 5 2.2.1 Outbreak Alert and Specialized Surveillance Networks …………………….. 5 2.2.2 Global Public Health Intelligence Network(GPHIN) ……………………….. 5 2.2.3 FluNet ………………………………………………………………………... 5 2.2.4 PACNET …………………………………………………………………….. 6 2.2.5 CDC Alert Systems ………………………………………………………….. 6 2.2.6 Outbreak Alert and Response at WHO …………………………………….... 6 2.2.7 IHR: A Mechanism for International Reporting ……………………………..
    [Show full text]
  • Optimal Vaccine Subsidies for Endemic and Epidemic Diseases Matthew Goodkin-Gold, Michael Kremer, Christopher M
    WORKING PAPER · NO. 2020-162 Optimal Vaccine Subsidies for Endemic and Epidemic Diseases Matthew Goodkin-Gold, Michael Kremer, Christopher M. Snyder, and Heidi L. Williams NOVEMBER 2020 5757 S. University Ave. Chicago, IL 60637 Main: 773.702.5599 bfi.uchicago.edu OPTIMAL VACCINE SUBSIDIES FOR ENDEMIC AND EPIDEMIC DISEASES Matthew Goodkin-Gold Michael Kremer Christopher M. Snyder Heidi L. Williams The authors are grateful for helpful comments from Witold Więcek and seminar participants in the Harvard Economics Department, Yale School of Medicine, the “Infectious Diseases in Poor Countries and the Social Sciences” conference at Cornell University, the DIMACS “Game Theoretic Approaches to Epidemiology and Ecology” workshop at Rutgers University, the “Economics of the Pharmaceutical Industry” roundtable at the Federal Trade Commission’s Bureau of Economics, the U.S. National Institutes of Health “Models of Infectious Disease Agent” study group at the Hutchinson Cancer Research Center in Seattle, the American Economic Association “Economics of Infectious Disease” session, and the Health and Pandemics (HELP!) Economics Working Group “Covid-19 and Vaccines” workshop. Maya Durvasula, Nishi Jain, Amrita Misha, Frank Schilbach, and Alfian Tjandra provided excellent research assistance. Williams gratefully acknowledges financial support from NIA grant number T32- AG000186 to the NBER. © 2020 by Matthew Goodkin-Gold, Michael Kremer, Christopher M. Snyder, and Heidi L. Williams. All rights reserved. Short sections of text, not to exceed two paragraphs, may be quoted without explicit permission provided that full credit, including © notice, is given to the source. Optimal Vaccine Subsidies for Endemic and Epidemic Diseases Matthew Goodkin-Gold, Michael Kremer, Christopher M. Snyder, and Heidi L.
    [Show full text]
  • A New Twenty-First Century Science for Effective Epidemic Response
    Review A new twenty-first century science for effective epidemic response https://doi.org/10.1038/s41586-019-1717-y Juliet Bedford1, Jeremy Farrar2*, Chikwe Ihekweazu3, Gagandeep Kang4, Marion Koopmans5 & John Nkengasong6 Received: 10 June 2019 Accepted: 24 September 2019 With rapidly changing ecology, urbanization, climate change, increased travel and Published online: 6 November 2019 fragile public health systems, epidemics will become more frequent, more complex and harder to prevent and contain. Here we argue that our concept of epidemics must evolve from crisis response during discrete outbreaks to an integrated cycle of preparation, response and recovery. This is an opportunity to combine knowledge and skills from all over the world—especially at-risk and afected communities. Many disciplines need to be integrated, including not only epidemiology but also social sciences, research and development, diplomacy, logistics and crisis management. This requires a new approach to training tomorrow’s leaders in epidemic prevention and response. connected, high-density urban areas (particularly relevant to Ebola, Anniversary dengue, influenza and severe acute respiratory syndrome-related coro- collection: navirus SARS-CoV). These factors and effects combine and interact, go.nature.com/ fuelling more-complex epidemics. nature150 Although rare compared to those diseases that cause the majority of the burden on population health, the nature of such epidemics disrupts health systems, amplifies mistrust among communities and creates high and long-lasting socioeconomic effects, especially in low- and When Nature published its first issue in 18691, a new understanding of middle-income countries. Their increasing frequency demands atten- infectious diseases was taking shape. The work of William Farr2, Ignaz tion.
    [Show full text]
  • Outbreak Response Protocols: K–12 the Following Document Is to Help Schools Develop a Plan Within Their Jurisdiction
    Outbreak Response Protocols: K–12 The following document is to help schools develop a plan within their jurisdiction. It is essential to work with Local Public Health to determine specific protocols for your location. MONTANA September 2020 Adapted from Rhode Island Outbreak Response Protocol: Pre-K–12 Table of Contents 2 Purpose of School Guidance and Directions for Use 3 Symptoms of COVID-19 Protocols to Respond to a Sick Person in Schools During 6 the COVID-19 Pandemic Additional Resources for Educating Teachers, Parents/Guardians and Children 10 When can a child or staff member return to school after travel? Student/Staff Symptom Screening Athletic and Extracurricular Guidance During COVID-19 COVID-19 Notification Guidance 16 Glossary 19 Acknowledgements Montana Outbreak Response Protocols: K–12 | Page 1 Purpose of School Guidance and Directions for Use uld I use What is How sho the ance? purpos this guid e of this guidance? Local Public Health (LPH) and schools should work together in the event of a case of COVID-19 in the school setting. This document will supplement that process. This guidance on how to respond if a child or staff member exhibits symptoms of COVID-19 or tests positive for COVID-19 can be used or adapted by local jurisdictions for all their schools; it does not address unique situation-specific questions that you may have. The guidance does not replace direct engagement with Local Public Health, but rather gives an overview of what will occur throughout that engagement process. The information in this document complements current Montana state and county guidelines and guidance.
    [Show full text]
  • Chapter 2 Disease and Disease Transmission
    DISEASE AND DISEASE TRANSMISSION Chapter 2 Disease and disease transmission An enormous variety of organisms exist, including some which can survive and even develop in the body of people or animals. If the organism can cause infection, it is an infectious agent. In this manual infectious agents which cause infection and illness are called pathogens. Diseases caused by pathogens, or the toxins they produce, are communicable or infectious diseases (45). In this manual these will be called disease and infection. This chapter presents the transmission cycle of disease with its different elements, and categorises the different infections related to WES. 2.1 Introduction to the transmission cycle of disease To be able to persist or live on, pathogens must be able to leave an infected host, survive transmission in the environment, enter a susceptible person or animal, and develop and/or multiply in the newly infected host. The transmission of pathogens from current to future host follows a repeating cycle. This cycle can be simple, with a direct transmission from current to future host, or complex, where transmission occurs through (multiple) intermediate hosts or vectors. This cycle is called the transmission cycle of disease, or transmission cycle. The transmission cycle has different elements: The pathogen: the organism causing the infection The host: the infected person or animal ‘carrying’ the pathogen The exit: the method the pathogen uses to leave the body of the host Transmission: how the pathogen is transferred from host to susceptible person or animal, which can include developmental stages in the environment, in intermediate hosts, or in vectors 7 CONTROLLING AND PREVENTING DISEASE The environment: the environment in which transmission of the pathogen takes place.
    [Show full text]
  • Epidemiological Characteristics of COVID-19 Ongoing Epidemic in Iraq
    Epidemiological Characteristics of COVID-19 Ongoing Epidemic in Iraq Abdul-Basset A. Al-Hussein , Fadihl Rahma Tahir1 ∗ Department of Electrical Engineering, University of Basrah, Basrah, Iraq *Corresponding author: Abdul-Basset A. Al-Hussein Email address: [email protected]; [email protected] 1 [email protected] (Submitted: 3 April 2020 – Published online: 6 April 2020) DISCLAIMER This paper was submitted to the Bulletin of the World Health Organization and was posted to the COVID-19 open site, according to the protocol for public health emergencies for international concern as described in Vasee Moorthy et al. (http://dx.doi.org/10.2471/BLT.20.251561). The information herein is available for unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited as indicated by the Creative Commons Attribution 3.0 Intergovernmental Organizations licence (CC BY IGO 3.0). RECOMMENDED CITATION Al-Hussein ABA & Tahir FR. Epidemiological Characteristics of COVID-19 Ongoing Epidemic in Iraq. [Preprint]. Bull World Health Organ. E-pub: 6 April 2020. doi: http://dx.doi.org/10.2471/BLT.20.257907 ABSTRACT Summary Epidemic models have been widely used in different forms for studying and forecasting epidemiological processes such as the spread of HIV, SARS, and influenza, and recently, the 2019–20 coronavirus which is an ongoing pandemic of coronavirus disease 2019 (COVID-19), that caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). To find the epidemic tendency and the main metrics of the outbreak of COVID-19 in Iraq. Method We considered a generalized SEIR model to simulate the ongoing spread of the disease and forecast the future behavior of the outbreak.
    [Show full text]
  • GE-Outbreak-Guidelines FINAL
    Guidelines for the Epidemiological Investigation and Control of Gastroenteritis Outbreaks (including Norovirus) Maryland Department of Health Infectious Disease Epidemiology and Outbreak Response Bureau November 2020 Contents Introduction .................................................................................................................................................. 3 Disease Description ....................................................................................................................................... 4 Definitions ..................................................................................................................................................... 5 Single Case Management .............................................................................................................................. 7 Outbreak Management................................................................................................................................. 8 Outbreak Control Measures for Special Settings ...................................................................................... 9 Specimen Collection .................................................................................................................................... 12 Submission of Food Samples ...................................................................................................................... 13 Data Collection and Summary Report .......................................................................................................
    [Show full text]
  • Infectious Disease Outbreak Response Plan
    Boone County Conservation District Infectious Disease Outbreak Response Plan ● Administrative Controls/Protocols: ○ Employees are directed to stay home when sick or have any of the symptoms identified in the Covid-19 posted signage. (see CDC and/or IDPH guidance) ■ Employees will notify their supervisor, which may/will trigger special sick leave criteria to be processed by the supervisor. See federal “Families First Coronavirus Response Act” requirements. ● https://www.dol.gov/agencies/whd/pandemic/ffcra-employer-paid-leave ○ Employees will self-quarantine for 14 days if exposed or known to have been in close contact with someone who has tested positive for COVID-19. ○ BCCD will require a daily, pre-work period health screening that includes: ■ Each staff member acknowledges their symptom status prior to starting work each day: ● Each employee will submit a Covid-19 symptoms checklist to their supervisor each day. ● Supervisors will retain these documents as part of the IDOR plan requirements. ■ Each staff member having a temperature check prior to entering their primary work area (building - i.e. Maintenance Building or Gustafson Nature Center). Anyone with a temperature of 100.4 degrees Fahrenheit or higher, or any other symptom of Covid-19 will need to go home. ○ The number of staff in the Gustafson Admin/Nature Center will be limited to four staff, not including temporary visits from non-office staff. One staff person per office space. ○ The number of public/visitors allowed in the Gustafson Admin/Nature Center will be limited to two people - no youth inside Nature Center (exceptions for translating). ○ The number of staff in the Maintenance Facility will be limited to: ■ Two people in Natural Resource Office Space ■ One person in Maintenance Office Space ■ Four people in Maintenance Garage/Repair Area ■ Two people in Wood-Working Shop Area ■ One person in Welding-Metals Shop Area ■ Three people in Native Seed Storage Area ■ Four people in Chum’s Building ○ Employee desks and/or workstations will be greater than six feet apart.
    [Show full text]
  • Chlamydia, Gonorrhea, and Syphilis
    CDC FACT SHEET Reported STDs in the United States, 2019 Sexually transmitted diseases (STDs) are a substantial health challenge facing the United States, and the epidemic disproportionately affects certain populations. Many cases of chlamydia, gonorrhea, and syphilis continue to go undiagnosed and unreported, and data on several other STDs, such as human papillomavirus and herpes simplex virus, are not routinely reported to CDC. As a result, national surveillance data only captures a fraction of America’s STD epidemic. CDC’s STD Surveillance Report provides important insight into the scope, distribution, and trends in STD diagnoses in the country. Strong public health infrastructure is critical to prevent and control STDs, especially among the most vulnerable groups. RECORD HIGH STDS THREATEN STD PREVENTION MILLIONS OF AMERICANS CHALLENGES Maintaining and strengthening core prevention infrastructure is essential to mounting 2,554,908 an effective national response. LIMITED RESOURCES make COMBINED CASES it challenging to quickly identify and treat STDs. State and local reductions in STD screening, treatment, prevention, REPORTED IN 2019 and partner services have resulted in staff layoffs, reduced clinic hours, and increased patient co-pays that can limit access to essential diagnosis and treatment services. Chlamydia Antibiotics can cure 1,808,703 cases chlamydia, gonorrhea, 553 per 100,000 people and syphilis. However, LEFT UNTREATED, these STDs put people, including Gonorrhea infants, at risk for severe, lifelong health outcomes like chronic pain, 616,392 cases reproductive health complications, 188 per 100,000 people and HIV. People who CANNOT Sy philis (all stages) GET STD CARE remain vulnerable to short- 129,813 cases 40 per 100,000 people and long-term health consequences and are Syphilis (primary and secondary) Syphilis (congenital) more likely to transmit infections 38,992 cases 1,870 cases to others—further compounding 1 2 per 100,000 people 49 per 100,000 live births America’s STD burden.
    [Show full text]
  • Municipal Infectious Disease Outbreak Response Plan Instructions The
    Municipal Infectious Disease Outbreak Response Plan Instructions The following sample plan is provided to assist you with the preparation and implementation of an effective infectious disease outbreak response plan. There are several areas in this sample plan that will need to be modified or customized, which will be indicated by BLUE TEXT. There are other areas that may not apply to your entity. We indicated guidance with highlighted text. Carefully review this entire plan to ensure it fits your entity and its operations. Name of Entity Municipal Infectious Disease Outbreak Response Plan Date Table of Contents INFECTIOUS DISEASE OUTBREAK RESPONSE PLAN .......................................................... 1 RESPONSIBILITIES .................................................................................................................. 1 INSERT TITLE .......................................................................................................................................... 1 Staff ........................................................................................................................................................... 2 STRATEGIES TO LIMIT TRANSMISSION OF INFECTIOUS DISEASE OUTBREAK ................ 4 Routes of Exposure ................................................................................................................................... 5 Pandemic Declaration ............................................................................................................................... 5
    [Show full text]